Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | SDK2 |
| Upstream (Parents) |
|---|
| (<<) CSTB → SDK2 |
| (<<) GPNMB → SDK2 |
| (<<) HDAC6 → SDK2 |
| (<<) HLA-G → SDK2 |
| (<<) IER3 → SDK2 |
| (<<) IGFBP6 → SDK2 |
| (<<) ITGB6 → SDK2 |
| (<<) MAP6D1 → SDK2 |
| (<<) MAPK11 → SDK2 |
| (<<) MEX3D → SDK2 |
| (<<) MLPH → SDK2 |
| (<<) NFIL3 → SDK2 |
| (<<) NOTCH2 → SDK2 |
| (<<) NRIP1 → SDK2 |
| (<<) ODC1 → SDK2 |
| (<<) PLA2G6 → SDK2 |
| (<<) SQLE → SDK2 |
| (<<) STX12 → SDK2 |
| (<<) WNT4 → SDK2 |
| Downstream (Children) |
|---|
| SDK2 → JMJD6 (>>) |
| SDK2 → MEF2D (>>) |
| SDK2 → MMP17 (>>) |
| SDK2 → TFF1 (>>) |
